Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A virus H5N1 vaccine - Novavax

Next Previous
X
Search
Drug Profile

Influenza A virus H5N1 vaccine - Novavax

Alternative Names: H5N1 Clade 2 VLP influenza virus vaccine - Novavax; H5N1 Virus-Like Particle (VLP) Influenza vaccine (recombinant) - Novavax; H5N1 virus-like particle pandemic influenza vaccine - Novavax

Latest Information Update: 17 Aug 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novavax
  • Developer Novavax; University of Hong Kong
  • Class Influenza A virus H5N1 vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Influenza A virus H5N1 subtype

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype(Prevention) in USA (IM, Injection)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-A-virus-H5N1-subtype(Prevention) in Hong Kong (IM, Injection)
  • 23 Sep 2014 BARDA modifies its contract with Novavax and awards an option period for Influenza-A virus H5N1 subtype vaccine development until September 2016

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top